Skip to content

Clinical trials

Phase 2 Malaria, Falciparum trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Malaria, Falciparum Phase: Phase 2 Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20066
20074
20083
20091
20101
20112
20132
20151
20164
20171
20182
20191
20202
20213
20224
20234
20244
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting6
Terminated4
Unknown status3
Active, not recruiting3
Not yet recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Novartis Pharmaceuticals6
Sanaria Inc.6
Medicines for Malaria Venture5
University of Oxford5
London School of Hygiene and Tropical Medicine3
National Institute of Allergy and Infectious Diseases (NIAID)3
U.S. Army Medical Research and Development Command3
Jomaa Pharma GmbH2
Medical University of Vienna2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria, Falciparum62
Malaria29
Malaria, Vivax4
Parasitic Diseases4
Coccidiosis2
Asymptomatic Infections1
Elimination Disorders1
Infections1
Lymphoma, Follicular1
Protozoan Infections1

Trials

Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.